Latest news with #PlentiGroup
News.com.au
01-05-2025
- Business
- News.com.au
New CDR rules give power back to the people, as well as fintech lenders
CDR flips the power back to the people Non-banks get their shot from 2026 Fintechs gear up for a fairer fight Back in 2019, Australian lawmakers kicked off something called the Consumer Data Right, or CDR. The idea was to give everyday Aussies the power to take back control of their personal financial data. Instead of banks and big institutions hoarding all the information, the CDR means people can choose to share them safely with trusted providers to get a better deal – whether that's on loans, power bills, or other services. It officially launched in mid-2020, starting with the big four banks. Since then, it's been rolled out to more financial players and even other industries. For consumers, the CDR has literally changed the game. If you're chasing a loan, for instance, you can now share your bank data directly with a lender who's signed up to the CDR framework. It means you can tell your bank, "Oi, send my data to this lender I actually want to deal with.' This allows those lenders to see your real financial habits, not just a credit score or a payslip. They can then make sharper decisions, and you could potentially score a better deal. And because the information is real-time and accurate, lenders can make quicker decisions, and the chance of defaults is lower, making everything run smoother for both sides. CDR to be expanded to non-bank lenders Now, the Australian Government is taking things even further. In a move announced last month, they've committed to expanding the CDR to non-bank lenders by mid-2026, opening up a whole new world of options for consumers. This is part of a much bigger plan to 'reset' the CDR and give Aussies more control. Stephen Jones, the Assistant Treasurer and Minister for Financial Services, said that 'uplifting' the CDR will 'deliver a better deal for more Australians.' The idea is to make sure that not only the banks, but also credit unions, fintech lenders, and buy-now-pay-later (BNPL) services, all get a piece of the action. By mid-2026, the CDR will include non-bank lending products like personal loans, car loans and even reverse mortgages. Tap straight into customers' data This will bode well for fintech lenders on the ASX. This includes companies like Plenti Group (ASX:PLT), which has surged in 2025 with record loan growth in Q4 and booming cash profit. Then there's Wisr (ASX:WZR), which is eyeing a 90% loan surge as AI powers 80% of its loan processing. MoneyMe, meanwhile, has powered past $1.5bn in its loan book, with originations up 65% and strong credit shaping a leaner, smarter portfolio. But these fintechs don't currently have the same access to real-time financial data that banks do, and that's where the expanded CDR comes in. Come mid-2026, the CDR will let MoneyMe and these other non-bank lenders tap straight into the financial data of consumers, data that until now has mostly been kept behind the walls of big banks. They can then potentially make faster, more accurate decisions about who qualifies for loans and under what terms. More muscle to compete But it's more than about speed. The CDR also opens the door to personalising loan products even more. For example, with MoneyMe now developing new credit card products, access to richer data through the CDR framework could be a game-changer. MoneyMe could look at a customer's actual spending habits, income trends, and even their history with other types of loans. And take car loans, for example. MoneyMe's got its own vehicle finance product called Autopay, while Plenti runs a white-label program called NAB powered by Plenti (NPBP). With the expanded CDR, these lenders could plug straight into a customer's real-time banking data. Armed with this kind of information, they could potentially design products that are better suited to each individual's lifestyle. This move also means that fintechs like MoneyMe will have more muscle to compete with the traditional banks. With CDR's expansion, everyone could well be playing on a more even field.
Yahoo
28-01-2025
- Business
- Yahoo
3 ASX Penny Stocks With Market Caps Larger Than A$100M To Watch
The Australian market has seen mixed performances recently, with the ASX200 closing slightly down amid sector shifts and reactions to global developments. Despite these fluctuations, certain investment opportunities continue to attract attention, particularly in sectors showing resilience or growth potential. Penny stocks, though often seen as a niche area, can offer intriguing prospects for investors when they are backed by strong financials and fundamentals. Name Share Price Market Cap Financial Health Rating Embark Early Education (ASX:EVO) A$0.78 A$139.45M ★★★★☆☆ LaserBond (ASX:LBL) A$0.58 A$68.57M ★★★★★★ SHAPE Australia (ASX:SHA) A$2.98 A$242.1M ★★★★★★ Austin Engineering (ASX:ANG) A$0.50 A$310.07M ★★★★★☆ GTN (ASX:GTN) A$0.53 A$108.01M ★★★★★★ Helloworld Travel (ASX:HLO) A$1.98 A$316.68M ★★★★★★ IVE Group (ASX:IGL) A$2.14 A$328.36M ★★★★☆☆ SKS Technologies Group (ASX:SKS) A$1.59 A$240.95M ★★★★★★ Vita Life Sciences (ASX:VLS) A$2.01 A$110.44M ★★★★★★ Centrepoint Alliance (ASX:CAF) A$0.33 A$65.63M ★★★★★☆ Click here to see the full list of 1,026 stocks from our ASX Penny Stocks screener. Let's review some notable picks from our screened stocks. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Plenti Group Limited operates in the fintech lending and investment sector in Australia, with a market capitalization of A$133.58 million. Operations: The company generates revenue of A$83.84 million from its financial services offerings. Market Cap: A$133.58M Plenti Group Limited, operating in the fintech lending sector, has shown significant revenue growth, reporting A$124.25 million for the half year ending September 2024. Despite being unprofitable with a high net debt to equity ratio (11169.4%), Plenti has managed to reduce its losses over the past five years and maintains a stable cash runway exceeding three years due to positive free cash flow. The company's board and management team are experienced, contributing to its strategic direction amidst volatility. Short-term assets significantly cover both short and long-term liabilities, indicating strong liquidity management. Dive into the specifics of Plenti Group here with our thorough balance sheet health report. Gain insights into Plenti Group's future direction by reviewing our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Race Oncology Limited is a clinical stage biopharmaceutical company dedicated to developing treatments for cancer patients, with a market cap of A$217.14 million. Operations: The company's revenue is derived entirely from its operations in Australia, amounting to A$4.00 million. Market Cap: A$217.14M Race Oncology Limited, a clinical stage biopharmaceutical company, remains pre-revenue with A$4 million in revenue and is currently unprofitable. Despite this, the company benefits from being debt-free and having sufficient cash runway for over a year. Recent strategic developments include the appointment of Dr. Megan Baldwin to its board as an Independent Non-Executive Director, bringing over 25 years of experience in oncology drug development and capital raising expertise. While Race Oncology's management team is relatively new, Dr. Baldwin's addition may enhance corporate governance and strategic initiatives in advancing its oncology programs. Click here to discover the nuances of Race Oncology with our detailed analytical financial health report. Explore Race Oncology's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Sovereign Metals Limited, along with its subsidiaries, focuses on the exploration and development of mineral resource projects in Malawi and has a market cap of A$452.91 million. Operations: Sovereign Metals Limited has not reported any revenue segments. Market Cap: A$452.91M Sovereign Metals Limited, currently pre-revenue with a market cap of A$452.91 million, focuses on its Kasiya Rutile-Graphite Project in Malawi. The company remains debt-free and has sufficient cash runway for over a year following recent capital raises. Recent mining trials at Kasiya have successfully demonstrated efficient extraction methods and initiated land rehabilitation efforts, underscoring the project's potential as a significant supplier to the titanium and graphite markets. While Sovereign's management team is relatively new, its experienced board may provide strategic guidance as it progresses towards commercial production amid ongoing environmental assessments. Click to explore a detailed breakdown of our findings in Sovereign Metals' financial health report. Learn about Sovereign Metals' future growth trajectory here. Click this link to deep-dive into the 1,026 companies within our ASX Penny Stocks screener. Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:PLT ASX:RAC and ASX:SVM. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
